Description of Collaborative Activity: |
The Regenerative Medicine Innovation Project was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA). |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
NIH Participating Institutes/Centers/Office of the Director: |
NCATS, NEI, NHLBI, NIA, NIAID, NIAMS, NIDCD, NIDCR, NIDDK, NINDS |
